Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin

Introduction | Browse | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
- 19(20) EpDPE cPLA2i 1.0 BCD110605C16 0.776 pmol/ml of medium
- 19(20) EpDPE cPLA2i 1.0 BCD110605C18 0.311 pmol/ml of medium
- 19(20) EpDPE cPLA2i 1.0 BCD110605C17 0.709 pmol/ml of medium
- 19(20) EpDPE cPLA2i 4.0 BCD110605C34 0.581 pmol/ml of medium
- 19(20) EpDPE cPLA2i 4.0 BCD110605C36 0.423 pmol/ml of medium
- 19(20) EpDPE cPLA2i 4.0 BCD110605C35 1.04 pmol/ml of medium
- 19(20) EpDPE cPLA2i 20.0 BCD110605C53 0.485 pmol/ml of medium
- 19(20) EpDPE cPLA2i 20.0 BCD110605C54 0.429 pmol/ml of medium
- 19(20) EpDPE cPLA2i 20.0 BCD110605C52 0.875 pmol/ml of medium
- 19(20) EpDPE PLDi 1.0 BCD110605C10 0.449 pmol/ml of medium
- 19(20) EpDPE PLDi 1.0 BCD110605C12 0.603 pmol/ml of medium
- 19(20) EpDPE PLDi 1.0 BCD110605C11 0.641 pmol/ml of medium
- 19(20) EpDPE PLDi 4.0 BCD110605C30 0.46 pmol/ml of medium
- 19(20) EpDPE PLDi 4.0 BCD110605C29 0.716 pmol/ml of medium
- 19(20) EpDPE PLDi 4.0 BCD110605C28 0.692 pmol/ml of medium
- 19(20) EpDPE PLDi 20.0 BCD110605C48 0.629 pmol/ml of medium
- 19(20) EpDPE PLDi 20.0 BCD110605C47 0.834 pmol/ml of medium
- 19(20) EpDPE PLDi 20.0 BCD110605C46 0.762 pmol/ml of medium
- 19(20) EpDPE KDO+cPLA2i 1.0 BCD110605C19 0.668 pmol/ml of medium
- 19(20) EpDPE KDO+cPLA2i 1.0 BCD110605C21 0.575 pmol/ml of medium
- 19(20) EpDPE KDO+cPLA2i 1.0 BCD110605C20 0.607 pmol/ml of medium
- 19(20) EpDPE KDO+cPLA2i 4.0 BCD110605C39 1.28 pmol/ml of medium
- 19(20) EpDPE KDO+cPLA2i 4.0 BCD110605C37 1.57 pmol/ml of medium
- 19(20) EpDPE KDO+cPLA2i 4.0 BCD110605C38 1.01 pmol/ml of medium
- 19(20) EpDPE KDO+cPLA2i 20.0 BCD110605C55 1.49 pmol/ml of medium
- 19(20) EpDPE KDO+cPLA2i 20.0 BCD110605C57 1.04 pmol/ml of medium
- 19(20) EpDPE KDO+cPLA2i 20.0 BCD110605C56 0.505 pmol/ml of medium
- 19(20) EpDPE KDO+PLDi 1.0 BCD110605C15 0.471 pmol/ml of medium
- 19(20) EpDPE KDO+PLDi 1.0 BCD110605C14 0.609 pmol/ml of medium
- 19(20) EpDPE KDO+PLDi 1.0 BCD110605C13 0.405 pmol/ml of medium
- 19(20) EpDPE KDO+PLDi 4.0 BCD110605C32 1.32 pmol/ml of medium
- 19(20) EpDPE KDO+PLDi 4.0 BCD110605C31 1.29 pmol/ml of medium
- 19(20) EpDPE KDO+PLDi 4.0 BCD110605C33 0.617 pmol/ml of medium
- 19(20) EpDPE KDO+PLDi 20.0 BCD110605C49 1.1 pmol/ml of medium
- 19(20) EpDPE KDO+PLDi 20.0 BCD110605C51 1.12 pmol/ml of medium
- 19(20) EpDPE KDO+PLDi 20.0 BCD110605C50 0.667 pmol/ml of medium
- 19(20) EpDPE KDO + ATP 1.0 BCD110605C07 0.448 pmol/ml of medium
- 19(20) EpDPE KDO + ATP 1.0 BCD110605C09 0.635 pmol/ml of medium
- 19(20) EpDPE KDO + ATP 1.0 BCD110605C08 0.654 pmol/ml of medium
- 19(20) EpDPE KDO + ATP 4.0 BCD110605C25 0.973 pmol/ml of medium
- 19(20) EpDPE KDO + ATP 4.0 BCD110605C26 0.877 pmol/ml of medium
- 19(20) EpDPE KDO + ATP 4.0 BCD110605C27 0.939 pmol/ml of medium
- 19(20) EpDPE KDO + ATP 20.0 BCD110605C45 1.19 pmol/ml of medium
- 19(20) EpDPE KDO + ATP 20.0 BCD110605C43 0.802 pmol/ml of medium
- 19(20) EpDPE KDO + ATP 20.0 BCD110605C44 1.14 pmol/ml of medium
- 19(20) EpDPE C 0.0 BCD110605C02 0.522 pmol/ml of medium
- 19(20) EpDPE C 0.0 BCD110605C01 0.419 pmol/ml of medium
- 19(20) EpDPE C 0.0 BCD110605C03 0.521 pmol/ml of medium
- 19(20) EpDPE C 1.0 BCD110605C06 0.623 pmol/ml of medium
- 19(20) EpDPE C 1.0 BCD110605C05 0.456 pmol/ml of medium